source
- STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and moreThe U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providersSTAT · 19d ago↗ source
- Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s AbogenNovartis is licensing an mRNA-based therapy designed to produce a CD3xCD19 T cell engager inside the body. Abogen Biosciences says the in vivo approach could reduce the likelihood of dangerous cyto…BioSpace · 19d ago↗ source
- Sanofi to pay $1 billion upfront to expand antibody partnership with RegeneronSanofi announced it will provide Regeneron with a $1 billion upfront payment to broaden their existing antibody collaboration. The agreement is timed as the patent protection for Dupixent, the joi…